Molecular Imaging: Page 50

FAPI-PET shows promise over conventional PET for identifying cancer

By Will Morton

Gallium-68 fibroblast activation protein inhibitor (FAPI) PET imaging may improve tumor detection in cancer patients over conventional imaging, according to a study published December 30 in the Journal of Nuclear Medicine.

January 4, 2023

NorthStar and Inhibrx ink deal on radiopharmaceutical development

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and biopharmaceutical company Inhibrx have inked a collaboration agreement for the development and production of new radiopharmaceuticals.

January 3, 2023

PET tracer shows promise in imaging of brain tumors

By Will Morton

A widely available amino acid PET radiotracer shows promise in helping clinicians distinguish between pseudoprogression and actual tumor progression in patients with brain tumors, according to a study published December 22 in the Journal of Nuclear Medicine.

January 3, 2023

PET/CT score may help predict major cardiac events

By Will Morton

Researchers have developed a clinical tool based on standard PET/CT imaging that could help cardiologists identify patients at high risk for heart attack and stroke, according to a study published online December 19 in the Journal of Nuclear Cardiology.

January 3, 2023

Bone scan capacity increased to meet COVID-19 backlog

By Will Morton

Radiologists in England facing a backlog of bone scan procedures for prostate cancer patients have developed a strategy for optimizing appointments that can significantly increase capacity, according to a study presented recently at RSNA 2022 in Chicago.

January 2, 2023

Tau PET best for predicting cognitive decline in AD patients

By Will Morton

Tau PET imaging consistently provides the best prediction of change in cognitive function in Alzheimer's disease patients with mild cognitive impairment or mild dementia, a Swedish group has found.

December 27, 2022

FAPI-PET visualizes myocardial fibrosis on molecular level

By Will Morton

PET imaging with a fibroblast activation protein inhibitor (FAPI) radiotracer can visualize myocardial fibrosis on the molecular level and could be a new diagnostic option for monitoring patients, according to a German group.

December 21, 2022

On Target secures new FDA approval for Cytalux

By AuntMinnie.com staff writers

Molecular imaging agent developer On Target Laboratories has received U.S. Food and Drug Administration (FDA) approval for an expanded indication on its Cytalux (pafolacianine) optical imaging agent.

December 20, 2022

Does the keto diet cloud brain PET imaging?

By Will Morton

Patients on ketogenic diets appear to have circulating metabolites that reduce the uptake of F-18 FDG radiotracer in brain PET imaging, according to an Australian group of researchers.

December 20, 2022

PET reveals risk of cardiovascular events in pneumonia patient

By Will Morton

FDG-PET/CT scans have shown that vascular inflammation may be a trigger for high rates of heart attack and other adverse events in patients with pneumonia, according to a study published online December 14 in JACC: Cardiovascular Imaging.

December 18, 2022

Fast acquisition techniques cut SPECT/CT bone scan times by half

By Will Morton

Whole-body SPECT/CT bone scan times to detect metastatic tumors in prostate cancer patients could be cut by half with the use of faster acquisition techniques, according to a study published December 12 in EJNMMI Physics.

December 18, 2022

CMS delays decision on amyloid PET coverage

By AuntMinnie.com staff writers

The U.S. Centers for Medicare and Medicaid Services (CMS) plans to take more time to review evidence in deciding whether to change coverage for amyloid PET scans for patients in clinical trials.

December 15, 2022

Previous Page

Page 50 of 613

Next Page